Why Leave An Established Career To Start A Biopharma?
Source: Life Science Leader
Sekar Kathiresan, M.D., spent 20 years as a cardiologist and genetics researcher. In this executive virtual roundtable (EVR) segment (view full video here), Kathiresan, cofounder and CEO of Verve Therapeutics (a gene editing company focused on cardiovascular disease), discusses the impetus for opting to leave a well-established career to start his own biopharmaceutical company.
This website uses cookies to ensure you get the best experience on our website. Learn more